SCHEMBL6514788

SCHEMBL6514788

Cc1cccc(-c2nc3c(C)cccc3n2CC(O)C(C)(C)C)c1[N+](=O)[O-]

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.38
PKM P14618 2/20 0.38
TDP1 Q9NUW8 1/20 0.38
LMNA P02545 1/20 0.38
HPGD P15428 3/20 0.35
POLB P06746 2/20 0.35
TSHR P16473 2/20 0.35
SLC5A2 P31639 2/20 0.34
CASR P41180 1/20 0.34
MGAM O43451 1/20 0.33
GAA P10253 1/20 0.33
SI P14410 1/20 0.33
MGAM2 Q2M2H8 1/20 0.33
PPARG P37231 1/20 0.33
TLR8 Q9NR97 1/20 0.33
CYP3A4 P08684 1/20 0.33
DCTPP1 Q9H773 2/20 0.32
MAPT P10636 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6520390 0.92 ATM (0.36) ALDH1A1TDP1SLC5A2PPARGDCTPP1
SCHEMBL6513852 0.88 MGAM (0.44) ALDH1A1TDP1LMNAHPGDTSHR
SCHEMBL6512276 0.80 SLC5A2 (0.39) TDP1LMNATSHRSLC5A2CASR
SCHEMBL6512290 0.78 ATM (0.40) ALDH1A1TDP1PPARGDCTPP1SMN1; SMN2
SCHEMBL6514897 0.76 MGAM (0.46) ALDH1A1TDP1LMNAHPGDTSHR
SCHEMBL6511702 0.74 CFTR (0.47) ALDH1A1PKMLMNAHPGDTSHR
SCHEMBL6520363 0.72 MGAM (0.46) ALDH1A1TDP1LMNAHPGDTSHR
SCHEMBL6511599 0.71 MGAM (0.42) LMNACASRMGAMGAASI
SCHEMBL6520247 0.70 ALDH1A1 (0.40) ALDH1A1TDP1LMNAHPGDMGAM
SCHEMBL6514231 0.67 ATM (0.50) LMNACASRMGAMGAASI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050239767-A1 Intermolecular SNAr of the heterocycle-activated nitro and fluoro groups-application in the synthesis of polyazamacrocyclic ligands NATIONAL SCIENCE FOUNDATION 2005-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050239767-A1 Intermolecular SNAr of the heterocycle-activated nitro and fluoro groups-application in the synthesis of polyazamacrocyclic ligands TECR, PAICS, DCXR ALDH1A1 1812/4885PKM 1047/4885TDP1 2251/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.